Follow The Filings

DNA position history

The shares of Ginkgo Bioworks (DNA) that VIKING GLOBAL INVESTORS LP reported in each quarter’s 13F.

Equity, CL A NEW

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q3: 3,577,128 shares, $29M, 0.11% of portfolio, New
  2. 2024 Q4: 3,577,128 shares, $35M, 0.11% of portfolio
  3. 2025 Q1: 3,577,128 shares, $20M, 0.06% of portfolio
  4. 2025 Q2: 3,577,128 shares, $40M, 0.12% of portfolio
  5. 2025 Q3: 3,577,128 shares, $52M, 0.14% of portfolio
  6. 2025 Q4: 3,577,128 shares, $30M, 0.08% of portfolio
  7. 2026 Q1: 3,577,128 shares, $22M, 0.06% of portfolio
  8. 2026 Q2: 3,577,128 shares, $35M, 0.10% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders